The role of miR-29b in cancer: regulation, function, and signaling
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are endogenous small non-coding RNAs with the capacity to regulate gene expression post-transcriptionally. The miRNA-29 family consists of miR-29a, miR-29b, and miR-29c, among which miR-29b is the most highly expressed and is found at two genomic loci. Recently, numerous studies have demonstrated that aberrant expression of miR-29b is common in the majority of human cancers. miR-29b is known to critically affect cancer progression by functioning as a tumor suppressor. However, it may also act as an oncogene under certain conditions. In this review, we illustrate the role of miR-29b in cancer regulation, function, and signaling. This is the first review highlighting the role of miR-29b in cancer. Our review aims to summarize the effects of miR-29b on cancer activity and its interactions with target genes and signaling pathways, as well as to provide therapeutic implications for overcoming cancer chemoresistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, X., Zhao, X., Fiskus, W., Lin, J., Lwin, T., Rao, R., Zhang, Y., Chan, J. C., Fu, K., Marquez, V. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.003 · Cited by 276 · cited 1×
“11 Consistent with this finding, HDACs are overexpressed in chronic lymphocytic leukemia (CLL), thus silencing the expression of critical tumor suppressors miR-29b, miR-15a, and miR-16.”
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 2×
“They work as post-transcriptional regulators of gene expression by binding to the 3′-untranslated region (3′-UTR) of target mRNAs.(1,2) Because of their short sequence, these RNA molecules are able to mediate mRNA degradation by perfect base-pairing with target mRNAs or by translational blockade via imperfect base-pai…”
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
(2008) · doi:10.1038/nrg2290 · Cited by 5,199 · cited 1×
“4,5 The miR-29 family consists of miR-29a, miR-29b, and miR-29c, differing only in two or three bases. miR-29b includes two sub-family members, miR-29b1 and miR-29b2.”
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673 · cited 2×
“that may revert aberrant DNA methylation by directly targeting both DNMT3A and DNMT3B.(23,64) In addition, it was demonstrated that miR-29b directly targets the 3′”
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325 · cited 1×
“C-Myc is known to directly suppress miR-29s.(10) In addition, Zhang et al showed that miR-29 is repressed by MYC through cooperative regulation by histone deacetylase 3 and histone-lysine N-methyltransferase 2 (EZH2) in aggressive B-cell lymphomas (BCLs).”
Repression of protein synthesis by miRNAs: how many mechanisms?
Pillai, R. S., Bhattacharyya, S. N., & Filipowicz, W. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.007 · Cited by 1,108 · cited 1×
“Consequently, miRNAs can dictate cell fate, cell cycle regulation, as well as cell proliferation, differentiation, apoptosis, and invasion.(3) Cancer is one of the leading causes of death worldwide.”
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984 · cited 1×
“Since the association of miRNA expression and cancer chemosensitivity was first raised in CCA, many studies have indicated that miRNAs are involved in cancer chemosensitivity.(44) Meanwhile, accumulating evidence has revealed the vital role of miR-29b in cancer chemosensitivity.”
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834 · cited 1×
“ligand cytotoxicity, indicating that miR-29b is a regulator of Mcl-1 protein expression, and thereby regulates apoptosis.(31)”
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781 · cited 1×
“This in turn leads to a decrease in global DNA methylation and re-expression of p15 (INK4b) and ESR1, two tumor suppressors.(21) Moreover, miR-29 family members may exert demethylation effects through recurrently regulating the active DNA demethylation pathway members tet methylcytosine dioxygenase (TET1) and thymine…”
MicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758 · cited 1×
“However, many studies have demonstrated that an miRNA may be considered a tumor suppressor or a tumor promoter, depending on its targets in different tissues and cell types.(53) Controversial issues surrounding the role of miRNA expression have existed for a long time.”
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma
Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., Cheng, A., Hall, B. M., Qualman, S. J., Chandler, D. S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.006 · Cited by 593
Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma
Xiong, Y., Fang, J.-H., Yun, J.-P., Yang, J., Zhang, Y., Jia, W.-H., & Zhuang, S.-M. (2010) · Hepatology · doi:10.1002/hep.23380 · Cited by 563 · cited 2×
“These results suggested that apoptosis may be promoted by miR-29 via a mitochondrial pathway involving Mcl-1 and Bcl-2.”
Self-citationTcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181
Pekarsky, Y., Santanam, U., Cimmino, A., Palamarchuk, A., Efanov, A., Maximov, V., Volinia, S., Alder, H., Liu, C.-G., Rassenti, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3613 · Cited by 520 · cited 1×
“lymphoma 1 (TCL1), (Mcl-1), B-Myb, CDC42, and PIK3R1, have been characterized as targets of the miR-29 family.(33,62,63)”
MicroRNA 29b functions in acute myeloid leukemia
Garzon, R., Heaphy, C. E. A., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211938 · Cited by 459 · cited 3×
“Transcriptome analysis after ectopic transfection of synthetic miR-29b into leukemia cells indicates that miR-29b targets apoptotic, cell cycle, and proliferation pathways.(33) In addition, miR-29 may sensitize hepatocellular carcinoma (HCC) cells to apoptosis by directly targeting the anti-apoptotic molecules Bcl-2 a…”
Blum, W., Garzon, R., Klisovic, R. B., Schwind, S., Walker, A., Geyer, S., Liu, S., Havelange, V., Becker, H., Schaaf, L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002650107 · Cited by 450 · cited 1×
“In this way, levels of miR-29b could be taken as a predictive factor for stratification to decitabine treatment.(49,50) While miR-29b is responsible for enhancing cancer sensitivity, free synthetic miRNAs are easily degraded in O nc oT ar ge ts a nd T he ra py d ow nl oa de d fr om h ttp s: //w w w .”
Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing
Auyeung, V. C., Ulitsky, I., McGeary, S. E., & Bartel, D. P. (2013) · Cell · doi:10.1016/j.cell.2013.01.031 · Cited by 434 · cited 1×
“They work as post-transcriptional regulators of gene expression by binding to the 3′-untranslated region (3′-UTR) of target mRNAs.(1,2) Because of their short sequence, these RNA molecules are able to mediate mRNA degradation by perfect base-pairing with target mRNAs or by translational blockade via imperfect base-pai…”
Chou, J., Lin, J. H., Brenot, A., Kim, J.-W., Provot, S., & Werb, Z. (2013) · Nature Cell Biology · doi:10.1038/ncb2672 · Cited by 373 · cited 4×
“Furthermore, it targets ITGA6, ITGB1, and TGF-β, thereby indirectly affecting differentiation and epithelial plasticity.(16)”
InfluentialHan, Y.-C., Park, C. Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J.-B., Liu, M., Zou, Y., Weissman, I. L., & Gu, H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090831 · Cited by 290 · cited 4×
“This study showed that miR-29 targets the TET2 gene, which is a key tumor suppressor frequently mutated in hematopoietic malignancies. miR-29b, along with miR-125b, miR-29c, miR-101, and miR-7, is preferentially overexpressed in TET2-wild-type AML.”
InfluentialTranscriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB
Mott, J. L., Kurita, S., Cazanave, S. C., Bronk, S. F., Werneburg, N. W., & Fernandez‐Zapico, M. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22630 · Cited by 282 · cited 1×
“both commonly activated during the genesis of human malignancies.(13) The Wnt family is a group of secreted”
BackgroundWnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1389 · Cited by 271 · cited 1×
“This leads to carcinogenesis in a variety of cancers.(69,70) Aberrant”
TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4
Winbanks, C. E., Wang, B., Beyer, C., Koh, P., White, L., Kantharidis, P., & Gregorevic, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192625 · Cited by 270
Xu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264 · cited 1×
“The targeting of B7-H3 by miR-29 is implicated in immune escape by solid tumors.(67)”
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Wu, Y., Crawford, M., Mao, Y., Lee, R. J., Davis, I. C., Elton, T. S., Lee, L. J., & Nana-Sinkam, S. P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.14 · Cited by 223 · cited 1×
“In addition, Wu et al developed a cationic lipoplex-based carrier that efficiently delivered miR-29b, showing great potential in the development of miRNA-based therapeutics for lung cancer treatment.(52) In summary, evidence suggests that miR-29b is a critical regulator of cancer chemosensitivity, mostly through targe…”
BackgroundmiR-29 and miR-30 regulate B-Myb expression during cellular senescence
Martinez, I., Cazalla, D., Almstead, L. L., Steitz, J. A., & DiMaio, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017346108 · Cited by 221 · cited 1×
“lymphoma 1 (TCL1), (Mcl-1), B-Myb, CDC42, and PIK3R1, have been characterized as targets of the miR-29 family.(33,62,63)”
miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis
Kole, A. J., Swahari, V., Hammond, S. M., & Deshmukh, M. (2011) · Genes & Development · doi:10.1101/gad.1975411 · Cited by 220 · cited 1×
“Although the sequences of the two pre-miR-29b stems are different, the mature miR-29bs resulting from these two stem structures are identical.(6) miR-29b shares gene regulatory function with other members of the miR-29 family.”
Ru, P., Steele, R., Newhall, P., Phillips, N. J., Toth, K., & Ray, R. B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0100 · Cited by 200 · cited 2×
“In one study, epithelial cell marker and E-cadherin expression were enhanced, and N-cadherin, Twist, and Snail expression was downregulated.(40) In colon cancer cells, Poudyal et al demonstrated that a hexane extract in American Ginseng (HAG) suppressed the migration of colon cancer cells in which miR-29b played a key…”
Luna, C., Li, G., Qiu, J., Epstein, D. L., & González, P. (2009) · PubMed Central · Cited by 198
Sampath, D., Liu, C., Vasan, K., Sulda, M., Puduvalli, V. K., Wierda, W. G., & Keating, M. J. (2012) · Blood · doi:10.1182/blood-2011-05-351510 · Cited by 197 · cited 1×
“Consistent with this finding, HDACs are overexpressed in chronic lymphocytic leukemia (CLL), thus silencing the expression of critical tumor suppressors miR-29b, miR-15a, and miR-16.(12) In addition to c-Myc, miR-29 expression is also suppressed by hedgehog, nuclear factor kappa-light-chainenhancer of activated B cell…”
Analysis of microRNA-target interactions across diverse cancer types
Jacobsen, A., Silber, J., Harinath, G., Huse, J. T., Schultz, N., & Sander, C. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2678 · Cited by 196 · cited 1×
“Moreover, miR-29 family members may exert demethylation effects through recurrently regulating the active DNA demethylation pathway members tet methylcytosine dioxygenase (TET1) and thymine DNA glycosylase (TDG).(22) In multiple myeloma (MM) cells, the miR-29b target mRNAs, DNMT3A and DNMT3, reduce global DNA methylat…”
BackgroundHuang, X., Schwind, S., Yu, B., Santhanam, R., Wang, H., Hoellerbauer, P., Mims, A., Klisovic, R., Walker, A. R., Chan, K. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3191 · Cited by 193 · cited 1×
“A novel transferrin-conjugated nanoparticle delivery system for synthetic miR-29b (Tf-NP-miR-29b) was proved to be more efficient in targeting oncogenes and in increasing the therapy effects of decitabine.(51) In addition, Wu et al developed a cationic lipoplex-based carrier that efficiently delivered miR-29b, showing…”
Nguyen, T., Kuo, C., Nicholl, M. B., Sim, M.-S., Turner, R. R., Morton, D. L., & Hoon, D. S. B. (2011) · Epigenetics · doi:10.4161/epi.6.3.14056 · Cited by 192 · cited 1×
“However, despite the high similarity of mature miR-29a/b/c sequences, numerous studies have showed that different isoforms of the miR-29 family may exert distinct functions.(7,8) For instance, enhancer-binding protein-alpha (CEBPA) selectively regulates miR-29b expression at its miR-29a/b1 locus on chromosome 7q32.”
Rossi, M., Pitari, M. R., Amodio, N., Di Martino, M. T., Conforti, F., Leone, E., Botta, C., Paolino, F. M., Del Giudice, T., Iuliano, E., et al. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24306 · Cited by 185 · cited 1×
“A recent report by Rossi et al indicated that miR-29b negatively regulates human osteoclastic cell differentiation and function, and it showed that forced expression of miR-29b impairs OCL differentiation and overcomes OCL activation triggered by MM cells, indicating that miR-29b-based treatment may be useful for trea…”
Kong, G., Zhang, J., Zhang, S., Shan, C., Ye, L., & Zhang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019518 · Cited by 172 · cited 3×
“54 Kong et al demonstrated that miR-29a was upregulated in HCC induced by the hepatitis B virus X protein and promoted migration by targeting PTEN.”
InfluentialSlack, F. J., & Weidhaas, J. B. (2008) · New England Journal of Medicine · doi:10.1056/nejme0808667 · Cited by 170 · cited 1×
“miRNAs can act as either oncogenes or tumor suppressors.(4,5) The miR-29 family consists of miR-29a, miR-29b, and miR-29c, differing only in two or three bases.”
Mishra, A., Liu, S., Sams, G. H., Curphey, D. P., Santhanam, R., Rush, L. J., Schaefer, D., Falkenberg, L. G., Sullivan, L., Jaroncyk, L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.009 · Cited by 169 · cited 1×
“Drug targeting that reverses miR-29b repression cures the otherwise fatal large granular lymphocytic leukemia.(24) Suppressor of cytokine signaling-1 (SOCS-1) is a hypermethylated tumor suppressor gene.”
An Extensive Network of TET2-Targeting MicroRNAs Regulates Malignant Hematopoiesis
Cheng, J., Guo, S., Chen, S., Mastriano, S. J., Liu, C., D’Alessio, A. C., Hysolli, E., Guo, Y., Yao, H., Megyola, C. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.050 · Cited by 160 · cited 1×
“It will be interesting to elucidate the underlying mechanism of this effect.(56) In addition, miR-29b1 and miR-29c levels were higher in the bladder cancer cell line, T24, than in normal urothelial cells.”
BackgroundAmodio, N., Di Martino, M. T., Foresta, U., Leone, E., Lionetti, M., Leotta, M., Gullà, A. M., Pitari, M. R., Conforti, F., Rossi, M., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.175 · Cited by 158 · cited 1×
“In MM, miR-29b sensitizes MM cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1, which is a transcription factor endowed with oncogenic activity.(47) In addition, Mims et al demonstrated that an increase of miR-29b expression by AR-42, a potent histone dea…”
Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression
Santanam, U., Zanesi, N., Efanov, A., Costinean, S., Palamarchuk, A., Hagan, J. P., Volinia, S., Alder, H., Rassenti, L., Kipps, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007186107 · Cited by 155 · cited 1×
“In addition, Santanam et al reported that the expression of miR-29 family members was higher in indolent human B-cell CLL (B-CLL) than in aggressive B-CLL and normal CD19+ B cells.(54) Kong et al demonstrated that miR-29a was upregulated in HCC induced by the hepatitis B virus X protein and promoted migration by targe…”
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
Morita, S., Horii, T., Kimura, M., Ochiya, T., Tajima, S., & Hatada, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714647 · Cited by 153 · cited 1×
“30”
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Amodio, N., Leotta, M., Bellizzi, D., Di Martino, M. T., D’Aquila, P., Lionetti, M., Fabiani, F., Leone, E., Gullà, A. M., Passarino, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.675 · Cited by 149 · cited 2×
“23,64 In addition, it was demonstrated that miR-29b directly targets the 3 ′ untranslated region of PDPN and inhibits invasion, apoptosis, and proliferation of glioblastomas.”
Fu, J., Tang, W., Du, P., Wang, G., Chen, W., Li, J., Zhu, Y., Gao, J., & Cui, L. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-68 · Cited by 147 · cited 1×
“It may be attributed to different sample sizes, genetic backgrounds, clinical characteristics, or different technique platforms.(60) Further study is needed to elucidate the underlying mechanism.”
Steele, R., Mott, J. L., & Ray, R. B. (2010) · Genes & Cancer · doi:10.1177/1947601910371978 · Cited by 145
Kinoshita, T., Nohata, N., Hanazawa, T., Kikkawa, N., Yamamoto, N., Yoshino, H., Itesako, T., Enokida, H., Nakagawa, M., Okamoto, Y., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.607 · Cited by 145 · cited 1×
“Furthermore, a head and neck squamous cell carcinoma (HNSCC) study by Kinoshita et al showed that miR-29s inhibit cancer cell migration and invasion via silencing OF laminin γ2 (LAMC2) and α6 ITG (ITGA6) genes.(42)”
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
Blum, W., Schwind, S., Tarighat, S. S., Geyer, S., Eisfeld, A.-K., Whitman, S., Walker, A., Klisovic, R., Byrd, J. C., Santhanam, R., et al. (2012) · Blood · doi:10.1182/blood-2012-03-413898 · Cited by 135 · cited 1×
“In this way, levels of miR-29b could be taken as a predictive factor for stratification to decitabine treatment.(49,50) While miR-29b is responsible for enhancing cancer sensitivity, free synthetic miRNAs are easily degraded in O nc oT ar ge ts a nd T he ra py d ow nl oa de d fr om h ttp s: //w w w .”
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
Cittelly, D. M., Finlay-Schultz, J., Howe, E. N., Spoelstra, N. S., Axlund, S. D., Hendricks, P., Jacobsen, B. M., Sartorius, C. A., & Richer, J. K. (2012) · Oncogene · doi:10.1038/onc.2012.275 · Cited by 131 · cited 1×
“These findings may illustrate a new mechanism in the progression of hormone-responsive breast cancers.(18) In melanoma, the miR-29a/b1 cluster was upregulated by interferon-γ in a signal transducer and activator of transcription 1 (STAT1)-dependent way, adding a novel regulatory loop in interferon-γ-mediated Jak/STAT…”
miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma
Cortez, M. A., Nicoloso, M. S., Shimizu, M., Rossi, S., Gopisetty, G., Molina, J. R., Carlotti, C., Tirapelli, D., Neder, L., Brassesco, M. S., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20808 · Cited by 131 · cited 1×
“untranslated region of PDPN and inhibits invasion, apoptosis, and proliferation of glioblastomas.(65) Additionally, in”
miR-29b regulates migration of human breast cancer cells
Wang, C., Bian, Z., Wei, D., & Zhang, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0755-z · Cited by 120 · cited 1×
“In addition, miR-29b over-expression was correlated with an advanced tumor stage, lymph node metastasis, and poor prognosis, indicating that miR-29b may be useful as a molecular prognostic marker.(58) Wang et al demonstrated that C1q and tumor necrosis factor related protein 6 (C1QTNF6), SPARC, and COL4A2 are directly…”
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
Eyholzer, M., Schmid, S., Wilkens, L., Mueller, B. U., & Pabst, T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605751 · Cited by 115 · cited 1×
“9 Moreover, two putative responsive elements of the myeloid master regulator PU.1 (SPI1) were identified in the miR-29b2/ miR-29c gene.”
Schmitt, M. J., Philippidou, D., Reinsbach, S. E., Margue, C., Wienecke-Baldacchino, A., Nashan, D., Behrmann, I., & Kreis, S. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-41 · Cited by 113 · cited 1×
“19 In addition, CCAAT/enhancer-binding protein-alpha (CEBPA), a crucial factor for normal granulopoiesis that is frequently disrupted in acute myeloid leukemia (AML), was found to directly activate miR-29a/b1 expression.”
BackgroundOkamoto, K., Miyoshi, K., & Murawaki, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077623 · Cited by 108 · cited 1×
“In addition, two miR-29b target genes, phosphoinositide3-kinase regulatory subunit 1 (PIK3R1) and MMP-2, are responsible for the resistance of CCA Gem treatment.(45) In ovarian cancer, mouse mucin-1 (MUC1) aptamermiR-29b chimera (Chi-29b) can efficiently inhibit ovarian tumor growth through reducing phosphatase and te…”
Zhang, Y.-K., Wang, H., Leng, Y., Li, Z.-H., Yang, Y.-F., Xiao, F., Li, Q.-F., Chen, X.-Q., & Wang, L.-S. (2011) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2011.09.063 · Cited by 107 · cited 1×
“In human myeloma cell lines, forced miR-29b expression by using the target miRNA-29b expression vector (Ad5F11p-miR-29b) may induce apoptosis and elevate caspase-3 activation.(35) Meanwhile, p53, a tumor suppressor that induces apoptosis in many tumor types, is positively regulated by miR-29b.”
Gong, J.-N., Yu, J., Lin, H.-S., Zhang, X.-H., Yin, X.-L., Xiao, Z., Wang, F., Xs, W., Su, R. J., Shen, C., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.133 · Cited by 107 · cited 1×
“In a mouse AML model, intravenous injection of each miR-29 family member also significantly relieved leukemic symptoms.(37) The balance of osteoclast (OCL)-mediated bone resorption and osteoblast (OBL)-dependent bone formation is disrupted in MM cells, which impair OBL function and stimulate OCLs to generate lytic les…”
Amodio, N., Bellizzi, D., Leotta, M., Raimondi, L., Biamonte, L., D’Aquila, P., Di Martino, M. T., Calimeri, T., Rossi, M., Lionetti, M., et al. (2013) · Cell Cycle · doi:10.4161/cc.26585 · Cited by 99 · cited 3×
“miR-29b leads to promoter demethylation of SOCS-1, a hypermethylated tumor suppressor gene, thereby negatively regulating migration of MM and endothelial cells.(25) Furthermore, a head and neck squamous cell carcinoma (HNSCC) study by Kinoshita et al showed that miR-29s inhibit cancer cell migration and invasion via s…”
InfluentialTan, M., Wu, J., & Cai, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.123 · Cited by 84 · cited 2×
“in lung cancer cells blocks Wnt/b-catenin signaling and inhibits tumor growth.(28)”
Gautschi, O. P., Tepper, C. G., Purnell, P. R., Izumiya, Y., Evans, C. P., Green, T. P., Desprez, P. Y., Lara, P. N., Gandara, D. R., Mack, P. C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6403 · Cited by 84 · cited 1×
“The inhibitor of DNA binding/ differentiation 1 (ID1) has been identified as an important downstream mediator of Src. 71 On one hand, activated c-Src kinase can repress miR-29b through b-catenin and c-Myc signaling, thereby promoting ID1 expression and invasion.”
Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells
Aldaz, B., Sagardoy, A., Nogueira, L., Guruceaga, E., Grande, L., Huse, J. T., Aznar, M. A., Díez-Valle, R., Tejada-Solís, S., Alonso, M. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077098 · Cited by 76 · cited 1×
“In glioblastoma multiforme-initiating cells, functional studies also showed that miR-29a and miR-29b targeted Mcl-1 mRNA, increasing apoptosis.(32) In AML cell lines and primary samples, restoration of miR-29b induces apoptosis and significantly reduces tumorigenicity.”
A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng
Poudyal, D., Cui, X., Le, P. M., Hofseth, A. B., Windust, A. J., Nagarkatti, M., Nagarkatti, P. S., Schetter, A. J., Harris, C. C., & Hofseth, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075034 · Cited by 76 · cited 3×
“61 In prostate cancer cells, exogenous expression of miR-29b inhibited Mcl-1, COL1A1, COL4A1, and MMP-2.”
InfluentialRothschild, S. I., Tschan, M. P., Federzoni, E. A., Jaggi, R. B., Fey, M. F., Gugger, M., & Gautschi, O. P. (2012) · Oncogene · doi:10.1038/onc.2011.578 · Cited by 75
Galli, R., Paone, A., Fabbri, M., Zanesi, N., Calore, F., Cascione, L., Acunzo, M., Stoppacciaro, A., Tubaro, A., Lovat, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304610110 · Cited by 65 · cited 1×
“29 Interestingly, while miR-29b directly targets DNMTs, a recent study has demonstrated that it may also repress the activity of DNA demethylases, which have opposing roles in controlling the status of DNA methylation.”
BackgroundWnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines
Lin, Y., You, L., Xu, Z., He, B., Mikami, I., Thung, E., Chou, J. C., Kuchenbecker, K. M., Kim, J. H., Raz, D. J., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.220 · Cited by 65 · cited 1×
“This leads to carcinogenesis in a variety of cancers.(69,70) Aberrant”
Mims, A. S., Walker, A. R., Huang, X., Sun, J., Wang, H., Santhanam, R., Dorrance, A. M., Walker, C. J., Hoellerbauer, P., Tarighat, S. S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.342 · Cited by 64
miR-29b moulds the tumour microenvironment to repress metastasis
Melo, S. A., & Kalluri, R. (2013) · Nature Cell Biology · doi:10.1038/ncb2684 · Cited by 54 · cited 1×
“This study sheds light on the network of transcription factors, miRNAs, and the tumor microenvironment to control cancer metastasis.(16,39) It is well known that EMT is a critical step in tumor cell invasion and metastasis, and it correlates positively with poor patient prognosis.”
Growth Factor Signaling and Resistance to Cancer Chemotherapy
Zunyan Dai, Y., Huang, Y. S., & Sadée, W. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387746 · Cited by 53 · cited 1×
“Discovering a strategy to reverse the chemoresistance in cancer is urgently needed.(43) Since the association of miRNA expression and cancer chemosensitivity was first raised in CCA, many studies have indicated that miRNAs are involved in cancer chemosensitivity.”
Wang, C., Gao, C., Zhuang, J., Ding, C., & Wang, Y. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1288-x · Cited by 48 · cited 3×
“any one of these mRNAs may promote invasion of MCF-7 cells.(59) Notably, miR-29a was shown to directly target B7-H3, which encodes an immunomodulatory surface glycoprotein.”
InfluentialThe anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer
Dai, F., Zhang, Y., Zhu, X., Shan, N., & Chen, Y. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.07.112 · Cited by 47 · cited 1×
“In accordance with this, intraperitoneal injection of Chi-29b significantly increased apoptosis in paclitaxel-resistant OVCAR-3 cells, suggesting the anti-chemoresistant role of miR-29b in ovarian cancer.(46) In MM, miR-29b sensitizes MM cells to bortezomib-induced apoptosis through the activation of a feedback loop w…”
Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24
Xu, F., Zhang, Q., Cheng, W., Zhang, Z., Wang, J., & Ge, J. (2013) · Journal of International Medical Research · doi:10.1177/0300060513505266 · Cited by 35 · cited 1×
“Knockdown of miR-29b1 or miR-29c suppressed T24 cell growth, suggesting an oncogenic role for miR-29b.(57) In breast cancer cells, a study showed that miR-29b expression was higher in metastatic breast cancer cells and tissues than in low-metastatic breast cancer cells and tissues.”
The mechanism involved in the loss of PTEN expression in NSCLC tumor cells
Li, G., Zhao, J., Peng, X., Liang, J., Deng, X., & Chen, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.065 · Cited by 33 · cited 1×
“methylation of the PTEN promoter, thereby exerting tumor suppressive effects.(66)”
Pandey, M., Sultana, S., & Gupta, K. P. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.12.001 · Cited by 24 · cited 1×
“In lung cancer, it has also been demonstrated that DNMTs are targets of miRNA-29b.(27,28) In DU145 and TRAMP-C1 prostate and MDA-MB-231 breast cancer cells, activation of toll-like receptor 3 (TLR3) induces miRNA expression, including DNMT-targeting miR-29b, resulting in demethylation and re-expression of the oncosupp…”
Han, Y.-C., Park, C. Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J., Liu, M., Zou, Y.-R., Weissman, I. L., & Gu, H. (2010) · The Journal of Cell Biology · doi:10.1083/jcb1886oia12 · Cited by 15
Cited by
Lung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, T., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D., & Tzouvelekis, A. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 171
“and as a therapeutic agent for lung cancer(112, 113).”
BackgroundHao, J., Yan, F., Zhang, Y., Triplett, A., Zhang, Y., Schultz, D. A., Sun, Y., Zeng, J., Silverstein, K. A. T., Zheng, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2465 · Cited by 168
Klimkiewicz, K., Weglarczyk, K., Collet, G., Paprocka, M., Guichard, A., Sarna, M., Jozkowicz, A., Dulak, J., Sarna, T., Grillon, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.006 · Cited by 70
Metadata
- Authors
- Yang, J.-R., Yan, B., Guo, Q., Fu, F.-J., Wang, Z., Yin, Z., & Wei, Y.-B.
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2015-03
- Volume
- 8
- Pages
- 539
- ISSN
- 1178-6930 (ISSN-L)
- OpenAlex
- W1988286540
- Cited by
- 198
- References
- 71
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.